Evidence map›Paper›PMID 36502406›Full record

ReviewEmerging infectious diseases2022

Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020.

John Paul Bigouette, Anna W Callaghan, Morgane Donadel, Angela Montesanti Porter, Louie Rosencrans, Jacquelyn S Lickness, Sara Blough, Xi Li, Robert T Perry, A J Williams and 4 more

Open access · diamondAbstract readReview
In one paragraph

Review in Emerging infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. [Ranking of immunization programs in Latin America, 2020Revista panamericana de salud publica = Pan American journal of public health · 2024
    Article
  8. Article
  9. Article
  10. Global Responses to the COVID-19 PandemicEmerging infectious diseases · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

John Paul Bigouette
Anna W Callaghan
Morgane Donadel
Angela Montesanti Porter
Louie Rosencrans
Jacquelyn S Lickness
Sara Blough
Xi Li
Robert T Perry
A J Williams
Heather M Scobie
Benjamin A Dahl
Jeffrey McFarland
Christopher S Murrill

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global emergence of the COVID-19 pandemic in 2020 curtailed vaccine-preventable disease (VPD) surveillance activities, but little is known about which surveillance components were most affected. In May 2021, we surveyed 214 STOP (originally Stop Transmission of Polio) Program consultants to determine how VPD surveillance activities were affected by the COVID-19 pandemic throughout 2020, primarily in low- and middle-income countries, where program consultants are deployed. Our report highlights the responses from 154 (96%) of the 160 consultants deployed to the World Health Organization African Region, which comprises 75% (160/214) of all STOP Program consultants deployed globally in early 2021. Most survey respondents observed that VPD surveillance activities were somewhat or severely affected by the COVID-19 pandemic in 2020. Reprioritization of surveillance staff and changes in health-seeking behaviors were factors commonly perceived to decrease VPD surveillance activities. Our findings suggest the need for strategies to restore VPD surveillance to prepandemic levels.

Indexed as

COVID-19PoliomyelitisVaccine-Preventable DiseasesHumansPandemicsWorld Health Organizationcoronavirus diseaseCOVID-19measlespoliorubellaSARS-COV-2severe acute respiratory syndrome coronavirus 2surveillancevaccine-preventable diseasesviruses

Identifiers

PMID36502406
PMCPMC9745246
OpenAlexW4312067585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.